Top Abstract Purchase Related
Home
>
Node
>
Subnode

Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca (2+) -ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts

Schwinger, R.H.; Böhm, M.; Schmidt, U.; Karczewski, P.; Bavendiek, U.; Flesch, M.; Krause, E.G.; Erdmann, E.

Circulation 92(11): 3220-3228

1995

ISSN/ISBN: 0009-7322
PMID: 7586307
Document Number: 453684
Background: The aim of the present study was to investigate whether Ca-2+ uptake into the sarcoplasmic reticulum (SR) is altered in failing human myocardium resulting from dilated cardiomyopathy. Methods and Results: Ca-2+-ATPase (SERCA II) activity and Ca-2+-dependent 45Ca-2+ uptake (oxalate supported, steady state) in isolated vesicles from the SR (VSR) and in crude membrane preparations (CSR) (free Ca-2+, 0.01 to 100 mu-mol/L) from nonfailing (donor hearts, n = 13) and terminally failing (heart transplants, dilated cardiomyopathy, n = 17) human myocardium were studied. In the same hearts, protein levels (Western blot analysis) and mRNA levels (Northern blot analysis) of SERCA II and phospholamban were measured. Increasing concentrations of Ca-2+ were followed by an increased Ca-2+-ATPase activity and Ca-2+ uptake. Ca-2+ uptake activity and Ca-2+-ATPase activity in CSR preparations from failing myocardium were significantly reduced compared with nonfailing hearts (Ca-2+-ATPase, 163+-8 and 125+-7 nmol ATP/mg protein per minute for nonfailing tissue and failing tissue in New York Heart Association (NYHA) class IV, respectively; Ca-2+ uptake, 7.1 +- 0.8 and 3.5 +- 0.3 nmol/mg protein per minute in CSR from nonfailing and NYHA class IV hearts, respectively; P lt .05). In contrast, no significant difference was measured in VSR. In the same preparations (CSR and VSR), both SERCA II and phospholamban levels (Western blot technique with monoclonal antibodies) were unchanged in failing compared with nonfailing tissue. mRNA expression relative to GAPDH mRNA for SERCA IIa and for phospholamban was significantly reduced in failing human myocardium (P lt .05). Conclusions: These findings provide evidence that in failing human myocardium caused by dilated cardiomyopathy, protein levels of SERCA II and phospholamban are unchanged even though mRNA levels for SERCA II and phospholamban and the SERCA II function are reduced compared with nonfailing myocardium.

Document emailed within 1 workday
Secure & encrypted payments

Baker, D.L.; Hashimoto, K.; Grupp, I.L.; Ji, Y.; Reed, T.; Loukianov, E.; Grupp, G.; Bhagwhat, A.; Hoit, B.; Walsh, R.; Marban, E.; Periasamy, M. 1998: Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts Circulation Research 83(12): 1205-1214
Linck, B.; Bokník, P.; Baba, H.A.; Eschenhagen, T.; Haverkamp, U.; Jäckel, E.; Jones, L.R.; Kirchhefer, U.; Knapp, J.; Läer, S.; Müller, F.U.; Schmitz, W.; Scholz, H.; Syska, A.; Vahlensieck, U.; Neumann, J. 1998: Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle Journal of Pharmacology and Experimental Therapeutics 286(1): 531-538
Takács, I.E.; Szabó, J.; Nosztray, K.; Szegi, J. 1981: Comparison of ATPase activity of cardiac sarcoplasmic reticulum fraction from rat and dog Acta Biologica Academiae Scientiarum Hungaricae 32(1): 75-81
Mas-Oliva, J. 1992: Effect of calmodulin on sarcoplasmic reticulum Ca(2+)-ATPase isolated from cardiac muscle Cardioscience 3(2): 107-115
Kasama, S.; Toyama, T.; Hoshizaki, H.; Oshima, S.; Taniguchi, K.; Iwasaki, T.; Suzuki, T.; Nagai, R. 2000: Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy Journal of Cardiology 36(1): 29-35
Pessah, I.N.; Durie, E.L.; Schiedt, M.J.; Zimanyi, I. 1990: Anthraquinone-sensitized Ca2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy Molecular Pharmacology 37(4): 503-514
Martins, E.; Faria, T.; Silva-Cardoso, J.; Oliveira, A.; Campelo, M.; Amorim, S.; Moura, B.; Rocha-Gonçalves, F.; Pereira, J.G.; Maciel, M.J.úl. 2009: I-123-MIBG cardiac uptake imaging, in familial dilated cardiomyopathy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(1): 29-36
Feng, H.S. 1992: Correlation of intra-erythrocytic Na, K, Ca, Mg contents and ATPase activity with dilated cardiomyopathy Zhonghua Yi Xue Za Zhi 72(9): 547-549; 574
Lelakowski, J.; Rydlewska, A.; Lelakowska, M.; Pudło, J.; Piekarz, J. 2017: The evaluation of the ventricular arrhythmias and interventions of cardiac implantable electronic devices in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death in ambulatory and telemetric follow-up Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(247): 13-20
Piszczek, I.; Błaszyk, K.; Poprawski, K. 1992: Non-invasive evaluation of function in both cardiac ventricles and arrhythmias in patients with dilated cardiomyopathy Polski Tygodnik Lekarski 47(40-41): 890-893
Gubskiĭ, I.I.; Zadorina, O.V.; Fedorov, A.N.; Bogdanova, L.A. 1991: Peroxide modification of skeletal muscle sarcoplasmic reticulum in antioxidant deficiency and under the action of ionol. I. Calcium transport into sarcoplasmic reticulum membranes Ukrainskii Biokhimicheskii Zhurnal 63(4): 81-87
Qian, H.; Ma, C.L. 1988: Suppressor cell activity in patients with idiopathic dilated cardiomyopathy Zhonghua Xin Xue Guan Bing Za Zhi 16(2): 68-71; 125
Vaĭkhanskaia, T.G.; Kurushko, T.V.; Sidorenko, I.V.; Koptiukh, T.M.; Gul', L.M.; Mel'nikova, O.P.; Golenishcha, V.F.; Kovalenko, O.N. 2013: Electrocardiographic predictors of response to cardiac resynchronization therapy of heart failure in patients with dilated cardiomyopathy Kardiologiia 53(3): 48-54
Lushchak, V.I.; Rubtsov, A.M.; Boldyrev, A.A. 1983: Interaction of ATP with sarcoplasmic reticulum Ca2+-ATPase; effect on the conformational state of the enzyme Ukrainskii Biokhimicheskii Zhurnal 55(5): 507-512
Verbolovich, V.P.; Poletaev, A.V. 1975: Infra-red spectra and ATPase activity of cardiac sarcoplasmatic reticulum under extreme conditions Biokhimiia 40(3): 566-569
Stoĭda, L.V. 1983: Change in the molecular properties of sarcoplasmic reticulum Ca-ATPase during modification of the membranes with cholesterol Biulleten' Eksperimental'noi Biologii i Meditsiny 96(10): 38-40
Sánchez, G.A.; Casadoumecq, A.C.; Alonso, G.L.; Takara, D. 2010: Inhibitory effect of lidocaine on the sarcoplasmic reticulum Ca2+-dependent atpase from temporalis muscle Acta Odontologica Latinoamericana: Aol 23(2): 92-98
Branishte, T.A.; Kuznetzov, A.V.; Khuchua, Z.A.; Samko, A.N.; Naumov, V.G.; Semenovskiĭ, M.L.; Belenkov, I.N.; Saks, V.A. 1992: Cellular mechanisms of impaired cardiac energetics in patients with dilated cardiomyopathy: decrease in mitochondrial respiration and creatine kinase expression Kardiologiia 32(5): 13-16
Fu, Z.-Q.; Li, X.-Y.; Liu, X.-H.; Sun, S.; Liu, T.; Mi, Y.-F.; Zhou, S.-A.; Ye, W.-H.; Wang, Q.-S. 2008: Overexpression of sarcoplasmic reticulum calcium ATPase induced hemodynamic and proteomic changes in a dog model of heart failure Zhonghua Xin Xue Guan Bing Za Zhi 36(3): 260-265
Owens, K.; Ruth, R.C.; Weglicki, W.B.; Stam, A.C.; Sonnenblick, E.H. 1974: Fragmented sarcoplasmic reticulum of the cardiomyopathic Syrian hamster: lipid composition, Ca++ transport, and Ca++-stimulated ATPase Recent Advances in Studies on Cardiac Structure and Metabolism 4: 541-550